Development of a shared decision-making intervention to improve drug safety and to reduce polypharmacy in frail elderly patients living at home
- PMID: 37213749
- PMCID: PMC10194292
- DOI: 10.1016/j.pecinn.2022.100032
Development of a shared decision-making intervention to improve drug safety and to reduce polypharmacy in frail elderly patients living at home
Abstract
Objectives: For patients with geriatric frailty, reducing inappropriate medication is an important goal to improve patient safety in primary care. GP-side barriers include knowledge gaps, legal concerns, and lack of communication between the actors involved. The aim was to develop a multi-faceted intervention to facilitate deprescribing and shared prioritisation among frail elderlies with polypharmacy living at home.
Methods: Mixed methods study including: 1) scoping review on family conferences, expert panels; 2) group discussions with GPs, mapping of needs and challenges in Primary Care; 3) workshops and expert interviews with GPs, patient advocates, researchers as a basis for a theoretical intervention model; 4) piloting.
Results: A major challenge for GPs is to conduct a productive discussion with patients and family cares on deprescribing and drug safety. A guideline for a structured family conference with a medication check and geriatric assessment was developed and proved to be feasible in the pilot study.
Conclusion: The intervention developed to facilitate deprescribing and shared prioritisation of drug therapy based on family conferences seems suitable to be tested in a subsequent cRCT.
Innovation: Adapting family conferences to primary care for frail patients with polypharmacy.
Keywords: Deprescribing; Family Conference; Frailty; Polypharmacy; Primary Care.
© 2022 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
LinkOut - more resources
Full Text Sources
